Viking Holdings (VIK) reported better-than-expected Q3 results as capacity and occupancy improve. Read more here.

There aren't many biotechs that are more exciting than Viking Therapeutics ( VKTX -0.95%) right now. Thanks to its clinical-stage candidate for weight loss, there's a real chance that this competitor ...